Cargando…
Mucosal Immunization Has Benefits over Traditional Subcutaneous Immunization with Group A Streptococcus Antigens in a Pilot Study in a Mouse Model
Group A Streptococcus (GAS) is a major human pathogen for which there is no licensed vaccine. To protect against infection, a strong systemic and mucosal immune response is likely to be necessary to prevent initial colonization and any events that might lead to invasive disease. A broad immune respo...
Autores principales: | Shaw, Helen Alexandra, Remmington, Alex, McKenzie, Giselle, Winkel, Caroline, Mawas, Fatme |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10674289/ https://www.ncbi.nlm.nih.gov/pubmed/38006056 http://dx.doi.org/10.3390/vaccines11111724 |
Ejemplares similares
-
Multicomponent Vaccines against Group A Streptococcus Can Effectively Target Broad Disease Presentations
por: Shaw, Helen A., et al.
Publicado: (2021) -
Progress towards a glycoconjugate vaccine against Group A Streptococcus
por: Burns, Keira, et al.
Publicado: (2023) -
GMMA as an Alternative Carrier for a Glycoconjugate Vaccine against Group A Streptococcus
por: Palmieri, Elena, et al.
Publicado: (2022) -
Subcutaneous Streptococcus dysgalactiae GAPDH vaccine in mice induces a proficient innate immune response
por: An, Ran, et al.
Publicado: (2023) -
Regulation of Naturally Acquired Mucosal Immunity to Streptococcus pneumoniae in Healthy Malawian Adults and Children
por: Glennie, Sarah J., et al.
Publicado: (2012)